Substance abuse (including nicotine) in schizophrenic patients

Current Opinion in Psychiatry

Volumn 16, Issue 2, 2003, Pages 199-205

  McEvoy, Joseph P ^a   Allen, Trina B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nicotine; Schizophrenia; Smoking; Substance use disorders

Indexed keywords

ALCOHOL; CLOZAPINE; NICOTINE;

ANTISOCIAL BEHAVIOR; BEHAVIOR THERAPY; COMORBIDITY; CRIMINAL JUSTICE; DRUG DEPENDENCE; DRUG TARGETING; EYE TRACKING; HOMELESSNESS; HOSPITALIZATION; HUMAN; MENTAL PATIENT; NEUROPHYSIOLOGY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PREGNANCY; PROGENY; PSYCHOSOCIAL CARE; REVIEW; SCHIZOPHRENIA; SMOKING; SUBSTANCE ABUSE; SUICIDE;

EID: 0037336438     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200303000-00010     Document Type: Review

References (44)

1. Kavanaugh DJ, McGrath J, Saunders JB, et al. Substance misuse in patients with schizophrenia. Drugs 2002; 62:743-755. This is a comprehensive review and insightful synthesis of the literature on the epidemiology and management of SUD in patients with schizophrenia.
2. Phillips P, Johnson S. How does drug and alcohol misuse develop among people with psychotic illness? Soc Psychiatry Psychiatr Epidemiol 2001; 36:269-276.
3. Batel P. Addiction and schizophrenia. Eur Psychiatry 2000; 15:115-122.
4. Drake RE, Mueser KT. Managing comorbid schizophrenia and substance abuse. Curr Psychiatry Rep 2001; 3:418-422. Primarily reviews the excellent work this group has done regarding integrated treatment for comorbid SUD in patients with schizophrenia.
5. Hetlerstein DJ, Rosenthal RN, Miner CR. Integrating services for schizophrenia and substance abuse. Psychiatr Quart 2001; 72:291-306.
6. el-Guabaly N, Cathcart J, Currie S, et al. Smoking cessation approaches for persons with mental illness or addictive disorders. Psychiatr Serv 2002; 53:1166-1170.
7. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002; 159:1642-1652. Presents a current conceptualization of the physiology of SUD as evidenced through brain imaging studies.
8. Sevy S, Robinson DG, Solloway S, et al. Correlates of substance misuse in patients with first episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 2001; 1014:367-374. Provides a comprehensive report of the impact of SUD on the first-episode population followed in the Hillside Hospital programs.
9. Buhler B, Hambrecht M, Loffler W, et al. Precipitation and determination of the onset and course of schizophrenia by substance abuse. Schizophr Res 2002; 54:243-251. Provides a comprehensive report of the impact of SUD on the first-episode population followed in Mannheim.
10. Larsen TK, McGlashan TH, Johannessen JO, et al. Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatry 2001; 158:1917-1919.
11. Verdoux H, Liraud F, Gonzalez B, et al. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatr Scand 1999; 100:389-395.
12. Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophr Res 2002; 54:253-264.
13. Salyers MP, Mueser KT. Social functioning, psychopathology, and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res 2001; 48:109-123.
14. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001; 48:69-82. Reviews the correlates of comorbid SUD among out patients with schizophrenia.
15. Jackson CT, Fein D, Essock SM, Mueser KT. The effects of cognitive impairment and substance abuse on psychiatric hospitalizations. Commun Ment Health J 2001; 37:303-312.
16. Kamali M, Kelly L, Gervin M, et al. Insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatr Serv 2001; 52:161-166. Reviews the correlates of comorbid SUD among newly admitted inpatients with schizophrenia.
17. Duke PJ, Pantelis C, McPhillips MA, Banes TRE. Comorbid non-alcohol substance misuse among people with schizophrenia. Brit J Psychiatry 2001; 179:509-503.
18. Schofield N, Quinn J, Haddock G, Barrowclough L. Schizophrenia and substance misuse problems: a comparison between patients with and without significant carer contact. Soc Psychiatry Psychiatr Epidemiol 2001; 36:523-528.
19. Odell SM, Commander MJ. Risk factors for homelessness among people with psychotic disorders. Soc Psychiatry Psychiatr Epidemiol 2000; 35:394-401.
20. Opler LA, White L, Caton CLM, et al. Gender differences in the relationship of homelessness to symptom severity, substance abuse, and neuroleptic noncompliance in schizophrenia. J Nerv Ment Dis 2001; 189:449-456.
21. Walkup JT, McAlpine DD, Olfson M, et al. Is the substance abuse of inpatients with schizophrenia overlooked? Gen Hosp Psychiatry 2001; 23:26-30.
22. Dickey B, Normand SLT, Weiss RD, et al. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 2002; 53:861-867.
23. Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91:31-37. Focuses upon the infectious disease risks associated with comorbid SUD.
24. Kamali M, Kelly L, Gervin M, et al. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia. Acta Psychiatr Scand 2000; 101:452-456.
25. Gut-Fayand A, Derveaux A, Olie J-P, et al. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 2001; 102:65-72.
26. Meltzer HY. Suicide in schizophrenia: risk factors and clozapine treatment. J Clin Psychiatry 1998; 59 (Suppl 3):15-20.
27. Carol G, Smelson DA, Losonczy MF, Ziedonis D. A preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv 2001; 52:1029-1031.
28. Serper MR, Copersino ML, Richarme D, et al. Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients. J Subst Abuse 2000; 11:205-213.
29. Serper MR, Bergman A, Copersino ML, et al. Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Res 2000; 93:21-36.
30. Smelson DA, Davis CW, DiPano R, et al. Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. J Nerv Ment Dis 2002; 190:200-202.
31. Mueser KT, Essock SM, Drake RE, et al. Rural and urban differences in patients with a dual diagnosis. Schizophr Res 2001; 48:93-107.
32. Bell M, Greig T, Gill P, et al. Work rehabilitation and patterns of substance use among persons with schizophrenia. Psychiatr Serv 2002; 53:63-69.
33. Bennett ME, Bellack AS, Gearon JS. Treating substance abuse in schizophrenia. J Subst Abuse Treat 2001; 20:163-175.
34. Jordan LC, Davidson WS, Herman SE, Boots-Miller BJ. Involvement in 12-step programs among persons with dual diagnoses. Psychiatr Serv 2002; 53:894-896.
35. Green AI. What is the relationship between schizophrenia and substance abuse [letter]. Harv Ment Health Lett 2000; 17:8.
36. deLeon J, Diaz FJ, Rogers T, et al. Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophr Res 2002; 56:47-54. Documents the temporal pattern of smoking initiation among patients with schizophrenia.
37. deLeon J, Tracy J, McCann E, et al. Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital. Schizophr Res 2002; 56:55-65.
38. Sherr JD, Myers L, Avila MT, et al. The effects of nicotine on specific eye tracking measures in schizophrenia. Biol Psychiatry 2002; 52:721-728.
39. Brennan PA, Grekin ER, Mortensen EL, Medinick SA. Relationship of maternal smoking during pregnancy with criminal arrest and hospitalization for substance abuse in male and female adult offspring. Am J Psychiatry 2002; 159:48-54. Provides evidence for the effects of maternal smoking on the subsequent generation.
40. McChargue DE, Gulliver SB, Hitsman B. Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment? Addiction 2002; 97:785-793.
41. Hughes JR. Rigidity in measures of smoking cessation [commentary on Ref. [40]]. Addiction 2002; 97:798-799.
42. Gilbert DG. Yes! Smokers with schizophrenia will benefit from more flexible treatment approaches [commentary on Ref. [40]]. Addiction 2002; 97:96-797.
43. George TP, Vessicchio JC. Treating tobacco addiction in schizophrenia: where do we go from here? [commentary on Ref. [40]]. Addiction 2002; 97:795-796.
44. George TP, Vessicchio JC, Termine A, et al. A placebo-controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 2002; 52:53-61. Well designed study documenting the usefulness of bupropion for smoking cessation in patients with schizophrenia.